長野赤十字病院は、長野県長野市にある医療機関である。日本赤十字社長野県支部が設置する病院である。

During the past decade, Nagano Red Cross Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nagano Red Cross Hospital" #1 sponsor was "Boston Scientific Corporation" with 2 trials, followed by "Alexion" with 1 trials sponsored, "Chugai Pharmaceutical" with 1 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored and "Incyte Biosciences Japan GK" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nagano Red Cross Hospital" #1 collaborator was "Guidant Corporation" with 1 trials as a collaborator, "Japan Lung Cancer Society" with 1 trials as a collaborator and "Tokyo Medical and Dental University" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Nagano Red Cross Hospital" are "Arrhythmias, Cardiac" (1 trials), "Atypical Hemolytic Uremic Syndrome (aHUS)" (1 trials), "Colorectal Cancer" (1 trials), "Heart Failure" (1 trials) and "Lymphoma" (1 trials). Many other conditions were trialed in "Nagano Red Cross Hospital" in a lesser frequency.

Most popular intervention types in "Nagano Red Cross Hospital" are "Drug" (6 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Baricitinib" (1 trials), "Eculizumab" (1 trials), "JNJ-53718678 125 mg" (1 trials) and "JNJ-53718678 250 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nagano Red Cross Hospital" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Nagano Red Cross Hospital". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Nagano Red Cross Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Nagano Red Cross Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".